申请人:Eli Lilly and Company
公开号:US05521197A1
公开(公告)日:1996-05-28
This invention provides novel 5-HT.sub.1F agonists which are useful for the treatment of migraine and associated disorders having the following formula: ##STR1## wherein A, B, X, Y, Ar and n are defined in the specification.
这项发明提供了一种新型的5-HT.sub.1F激动剂,可用于治疗偏头痛和相关疾病,其化学结构如下:##STR1##其中A、B、X、Y、Ar和n在说明书中有定义。